Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men.

CONTEXT Estrogen treatment of men with prostate cancer is associated with increased cardiovascular morbidity and mortality; however, the role of endogenous estrogen levels for atherosclerotic disease in men is unknown. OBJECTIVE The objective of the study was to determine whether endogenous serum estradiol (E2) levels predict the progression of carotid artery intima-media thickness in men. DESIGN, SETTING AND PARTICIPANTS This was a population-based, prospective cohort study (the Atherosclerosis and Insulin Resistance study) conducted in Göteborg, Sweden, among 313 Caucasian men without cardiovascular or other clinically overt diseases. Carotid artery intima-media thickness, an index of preclinical atherosclerosis, was measured by ultrasound at baseline (58 yr of age) and after 3 yr of follow-up. Serum sex hormone levels and cardiovascular risk factors (body mass index, waist to hip ratio, systolic blood pressure, serum triglycerides, plasma c-peptide, and smoking status) were assessed at study entry. INTERVENTION There was no intervention. MAIN OUTCOME MEASURES Association between baseline total and free E2 levels and progression of carotid intima-media thickness over 3 yr with adjustments for cardiovascular risk factors was measured. RESULTS In univariate analyses, both total and free E2 levels at baseline were positively associated with the annual change in intima-media thickness. In linear regression models including E2 and cardiovascular risk factors, low-density lipoprotein and high-density lipoprotein cholesterol and E2 were identified as independent predictors of progression of carotid artery intima-media thickness (total E2 beta = 0.187, P = 0.001; and free E2 beta = 0.183, P = 0.003). CONCLUSIONS Circulating E2 is a predictor of progression of carotid artery intima-media thickness in middle-aged men. Further studies are needed to investigate the role of endogenous E2 for incident cardiovascular disease events.

[1]  R. Karas,et al.  Molecular and Cellular Basis of Cardiovascular Gender Differences , 2005, Science.

[2]  O. Raitakari,et al.  Increased carotid atherosclerosis in andropausal middle-aged men. , 2005, Journal of the American College of Cardiology.

[3]  V. Miller,et al.  Correlating androgen and estrogen steroid receptor expression with coronary calcification and atherosclerosis in men without known coronary artery disease. , 2005, The Journal of clinical endocrinology and metabolism.

[4]  B. Fagerberg,et al.  Oxidized low‐density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men , 2004, Journal of internal medicine.

[5]  A. Villablanca,et al.  Susceptibility to Early Atherosclerosis in Male Mice Is Mediated by Estrogen Receptor α , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[6]  C. Schmid,et al.  Association between estrogen receptor α gene variation and cardiovascular disease , 2004 .

[7]  D. Grobbee,et al.  Endogenous Sex Hormones and Progression of Carotid Atherosclerosis in Elderly Men , 2004, Circulation.

[8]  Ravinder J. Singh,et al.  Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. , 2004, Clinical chemistry.

[9]  P. Hopkins,et al.  Estrogen receptor 1 variants and coronary artery disease: shedding light into a murky pool. , 2003, JAMA.

[10]  D. Grobbee,et al.  Endogenous sex hormones and cardiovascular disease in men. , 2003, The Journal of clinical endocrinology and metabolism.

[11]  David Handelsman,et al.  Androgens and cardiovascular disease. , 2003, Endocrine reviews.

[12]  A. von Eckardstein,et al.  Androgens and coronary artery disease. , 2003, Endocrine reviews.

[13]  J. Hodgin,et al.  Minireview: estrogen and mouse models of atherosclerosis. , 2002, Endocrinology.

[14]  C. Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[15]  Markus Perola,et al.  Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study , 2002, Journal of Molecular Medicine.

[16]  M. Ala-opas,et al.  Parenteral Estrogen versus Combined Androgen Deprivation in the Treatment of Metastatic Prostatic Cancer - Scandinavian Prostatic Cancer Group (SPCG) Study No. 5 , 2002, Scandinavian journal of urology and nephrology.

[17]  B. Fagerberg,et al.  Insulin resistance and intima–media thickness in the carotid and femoral arteries of clinically healthy 58‐year‐old men. The Atherosclerosis and Insulin Resistance Study (AIR) , 2001, Journal of internal medicine.

[18]  B. Fagerberg,et al.  The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis: The Atherosclerosis and Insulin Resistance (AIR) Study , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[19]  D. Grobbee,et al.  Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. , 2000, The Journal of clinical endocrinology and metabolism.

[20]  P. Komesaroff,et al.  Cardiovascular Actions of Estrogens in Men , 1999 .

[21]  A. Vermeulen,et al.  A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.

[22]  M. Mendelsohn,et al.  Protective effects of estrogen on the cardiovascular system. , 1999, The American journal of cardiology.

[23]  C Schmidt,et al.  How can the variability in ultrasound measurement of intima-media thickness be reduced? Studies of interobserver variability in carotid and femoral arteries. , 1999, Clinical physiology.

[24]  R. Kronmal,et al.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.

[25]  M. Ruutu,et al.  Parenteral polyoestradiol phosphate vs orchidectomy in the treatment of advanced prostatic cancer. Efficacy and cardiovascular complications: a 2-year follow-up report of a national, prospective prostatic cancer study. Finnprostate Group. , 1998, British journal of urology.

[26]  T Gustavsson,et al.  A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness. , 1997, Stroke.

[27]  Arno W. Hoes,et al.  Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. , 1997, Circulation.

[28]  P. D. de Feyter,et al.  Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. , 1997, Stroke.

[29]  B. Pinkernell,et al.  The association of hyperestrogenemia with coronary thrombosis in men. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[30]  E. Crawford,et al.  Estrogens in the treatment of prostate cancer. , 1995, The Journal of urology.

[31]  W. Castelli,et al.  Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort. , 1983, The American journal of medicine.

[32]  O. Faber,et al.  C-peptide Metabolism and the Liver , 1978, Diabetes.

[33]  M. Bots,et al.  Endogenous hormones and carotid atherosclerosis in elderly men. , 2003, American journal of epidemiology.

[34]  B. Fagerberg,et al.  The euglycemic hyperinsulinemic clamp examination: variability and reproducibility. , 2000, Scandinavian journal of clinical and laboratory investigation.